Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,824Revenue (TTM) $M124Net Margin (%)-128.6Altman Z-Score0.7
Enterprise Value $M4,958EPS (TTM) $-0.7Operating Margin %-79.6Piotroski F-Score6
P/E(ttm)--Beneish M-Score3.7Pre-tax Margin (%)-128.5Higher ROA y-yY
Price/Book15810-y EBITDA Growth Rate %--Quick Ratio2.1Cash flow > EarningsY
Price/Sales34.35-y EBITDA Growth Rate %--Current Ratio2.1Lower Leverage y-yY
Price/Free Cash Flow48.7y-y EBITDA Growth Rate %--ROA % (ttm)-36.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M286ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with EXEL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EXELJoel Greenblatt 2016-09-30 Add0.02%$8.04 - $15.48
($10.81)
$ 16.8456%Add 498.39%130,059
EXELJoel Greenblatt 2016-06-30 Buy $4 - $7.85
($5.74)
$ 16.84193%New holding21,735
EXELCharles Brandes 2016-03-31 Sold Out $3.64 - $5.64
($4.25)
$ 16.84296%Sold Out0
EXELCharles Brandes 2015-12-31 Reduce$4.79 - $6.33
($5.59)
$ 16.84201%Reduce -44.88%14,000
EXELCharles Brandes 2015-06-30 Buy $2.57 - $4.03
($3.24)
$ 16.84420%New holding25,400
EXELFirst Eagle Investment 2014-06-30 Sold Out -0.0038%$3.22 - $3.8
($3.45)
$ 16.84388%Sold Out0
EXELFirst Eagle Investment 2014-03-31 Reduce-0.01%$3.38 - $8.24
($6.84)
$ 16.84146%Reduce -65.91%400,000
EXELFirst Eagle Investment 2012-09-30 Add0.02%$4.28 - $6.45
($5.29)
$ 16.84218%Add 422.58%1,175,800
EXELFirst Eagle Investment 2012-03-31 Add$4.49 - $6.47
($5.14)
$ 16.84228%Add 125.00%225,000
EXELFirst Eagle Investment 2011-12-31 Buy $3.95 - $7.81
($5.01)
$ 16.84236%New holding100,000
EXELCarl Icahn 2011-09-30 Sold Out -0.43%$5.5 - $9.22
($7.34)
$ 16.84129%Sold Out0
EXELFirst Eagle Investment 2011-03-31 Sold Out -0.01%$7.22 - $12.45
($9.95)
$ 16.8469%Sold Out0
EXELFirst Eagle Investment 2010-12-31 Buy 0.01%$3.98 - $9.08
($5.66)
$ 16.84198%New holding280,000
EXELFirst Eagle Investment 2009-12-31 Sold Out -0.02%$5.33 - $8
($6.84)
$ 16.84146%Sold Out0
EXELFirst Eagle Investment 2009-09-30 Buy 0.02%$4.4 - $6.99
($5.65)
$ 16.84198%New holding274,700
EXELFirst Eagle Investment 2009-06-30 Sold Out -0.01%$4.16 - $5.55
($4.87)
$ 16.84246%Sold Out0
EXELFirst Eagle Investment 2009-03-31 Reduce$4.32 - $5.85
($4.8)
$ 16.84251%Reduce -25.67%144,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EXEL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


EXEL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Garber Alan MDirector 2016-12-09Sell7,832$16.9-0.36view
SCANGOS GEORGE ADirector 2016-12-07Sell204,894$17.81-5.45view
Lamb PeterEVP, Scientific Strategy & CSO 2016-12-01Sell70,000$16.661.08view
Schwab GiselaPres Prod Dev & Med Aff & CMO 2016-12-01Sell22,000$16.730.66view
MORRISSEY MICHAELPresident and CEO 2016-11-09Sell200,000$1512.27view
Schwab GiselaPres Prod Dev & Med Aff & CMO 2016-11-09Sell22,000$1512.27view
Lamb PeterEVP, Scientific Strategy & CSO 2016-11-09Sell70,000$13.1528.06view
Schwab GiselaPres Prod Dev & Med Aff & CMO 2016-08-31Sell131,155$10.9853.37view
Schwab GiselaPres Prod Dev & Med Aff & CMO 2016-08-04Sell42,338$1153.09view
WILLSEY LANCEDirector 2016-05-11Buy60,000$4.97238.83view

Quarterly/Annual Reports about EXEL:

News about EXEL:

Articles On GuruFocus.com
The Best-Performing Non-S&P Stocks of 2015 Dec 30 2015 
5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and Aeropostale I Dec 28 2014 
5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc. Sep 28 2014 
Weekly 3-Year Low Highlights: UAN, CLD, EXEL, QNST Sep 06 2014 
Five-Year Lows: Rentech Nitrogen Partners LP, SandRidge Permian Trust, Millennial Media Inc., Exelix May 05 2014 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
Exelixis Inc. Reports Operating Results (10-K) Feb 22 2011 
Exelixis Inc. (EXEL) CFO Frank Karbe buys 16,500 Shares Aug 25 2010 
Exelixis Inc. Reports Operating Results (10-Q) Aug 05 2010 
Exelixis Inc. Reports Operating Results (10-Q) May 11 2010 

More From Other Websites
Earnings Estimates Moving Higher for Exelixis (EXEL): Time to Buy? Dec 07 2016
Exelixis Announces Leadership Hires in Public Affairs and Business Development to Support Growth of... Dec 07 2016
Hedge Funds Aren’t Crazy About John Bean Technologies Corp (JBT) Anymore Dec 05 2016
Exelixis (EXEL): Strong Industry, Solid Earnings Estimate Revisions Dec 01 2016
Is Wright Medical Group Inc (WMGI) a Good Stock for Your Portfolio? Nov 30 2016
Exelixis to Present at the BMO Prescription for Success Healthcare Conference on December 14 Nov 30 2016
Hedge Funds Are Buying RealPage, Inc. (RP) Nov 30 2016
Should You Buy Exelixis, Inc. (EXEL)? Nov 30 2016
Shark Bites: Eager Buyers Pounce on Pullback Nov 29 2016
The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3 Nov 24 2016
4 stocks to watch Nov 23 2016
EXELIXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Nov 22 2016
Exelixis to Present at the Piper Jaffray 28th Annual Healthcare Conference on November 29 Nov 21 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)